Overview
Dr. Xing-Yang Xue is a male Chief Physician, MD/PhD, Master's Supervisor, and Visiting Scholar (USA). Recognized as a Guangdong Outstanding Young Medical Talent, he is a key expert in the Thoracic Surgery Department at the First Affiliated Hospital of Guangzhou Medical University (Affiliated Tumor Hospital). He specializes in minimally invasive precision diagnosis and comprehensive treatment of pulmonary nodules, lung cancer, and thoracic tumors.
Clinical focus & conditions
1. Pulmonary Oncology
Lung Cancer: Full-spectrum care for Early-stage and Advanced malignancies.
Nodule Management: Differential diagnosis of Ground-Glass (GGO/GGN) and solid nodules.
Metastatic Disease: Surgical and systemic treatment for Pulmonary Metastases.
2. Mediastinal & Esophageal
Mediastinal Tumors: Management of Thymoma, cysts, and neurogenic masses.
Esophageal Cancer: Comprehensive surgical and multidisciplinary treatment.
3. Pleural & Chest Wall
Pleural Malignancies: Treatment of Mesothelioma and metastatic pleural disease.
Fluid Management: Advanced diagnostic workup for Pleural Effusion.
Breast Oncology: Comprehensive care for benign and malignant Breast Tumors.
Education & training
MD,Ph.D. — Sichuan University
Training — Northwestern University Cancer Center, USA
Hospital affiliations
The first affiliated hospital of Guangzhou medical university
Honors & Research
Honors:
Guangdong Outstanding Young Medical Talent, Guangdong Health Science Popularization Expert, Yangcheng Good Doctor, etc.
Academic Positions:
Committee Member of Tumor Metastasis Committee, China Anti-Cancer Association; Youth Committee Member of Tumor Microenvironment Committee, China Anti-Cancer Association; Deputy Head of MTA Lung Cancer MDT Expert Group, China Hospital Association; Standing Committee Member of Oncology Committee, Guangdong Clinical Medicine Society, and other key national/provincial positions; Youth Editorial Board Member of Chinese Journal of Lung Cancer.
Research:
Led 12 provincial/municipal lung cancer projects and participated in 4 National Natural Science Foundation projects; published over 10 SCI papers in journals such as GUT and Oncogene, and over 40 Chinese academic papers; co-authored/edited 6 monographs. Primary research focuses on new models of comprehensive treatment centered on lung cancer surgery, mechanisms of targeted/immunotherapy resistance in lung cancer, pleural metastasis, and multi-nodular lung disease.
Is my case a fit for a second opinion?
A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.
Important note
This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.